SEC Filing Details

SEC Filing Details

Document Details

Form
6-K
Filing Date
May 17, 2022
Document Date
March 31, 2022
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
VBL Therapeutics
Issuer
Vascular Biogenics Ltd.